MedTrace Logo

Acceptability of the NuvaRing Among Students

NCT00635570 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 273

Last updated 2021-02-03

Study results available
· View outcomes & findings →

Summary

The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing® vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students.

Conditions

  • Birth Control Compliance

Interventions

DRUG

Ortho Tri-cyclen Lo

Low dose oral contraceptive

DEVICE

NuvaRing

Contraceptive vaginal ring

Sponsors & Collaborators

  • Organon

    collaborator INDUSTRY

  • University of Chicago

    lead OTHER

Principal Investigators

  • Melissa L Gilliam, MD, MPH · University of Chicago, Section of Family Planning

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-01-31
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00635570 on ClinicalTrials.gov